IXSBF (InNexus Biotechnology) Long-Term Debt : $0.27 Mil (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Long-Term Debt?

InNexus Biotechnology's Long-Term Debt for the quarter that ended in Mar. 2011 was $0.27 Mil.

InNexus Biotechnology's quarterly Long-Term Debt declined from Sep. 2010 ($0.36 Mil) to Dec. 2010 ($0.34 Mil) and declined from Dec. 2010 ($0.34 Mil) to Mar. 2011 ($0.27 Mil).

InNexus Biotechnology's annual Long-Term Debt increased from Jun. 2008 ($0.00 Mil) to Jun. 2009 ($2.28 Mil) but then declined from Jun. 2009 ($2.28 Mil) to Jun. 2010 ($0.00 Mil).

InNexus Biotechnology Long-Term Debt Historical Data

The historical data trend for InNexus Biotechnology's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Long-Term Debt Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Long-Term Debt

Get a 7-Day Free Trial

2.28

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Long-Term Debt	Get a 7-Day Free Trial															-	-	0.36	0.34	0.27

InNexus Biotechnology (GREY:IXSBF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

InNexus Biotechnology Long-Term Debt Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology Headlines

No Headlines